Tandem Diabetes Care, Inc. (TNDM)
17.02
-1.46
(-7.90%)
USD |
NASDAQ |
Nov 17, 16:00
17.60
+0.58
(+3.41%)
After-Hours: 20:00
Tandem Diabetes Care Enterprise Value : 1.583B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.583B |
| November 13, 2026 | 1.693B |
| November 12, 2026 | 1.515B |
| November 11, 2026 | 1.603B |
| November 10, 2026 | 1.599B |
| November 09, 2026 | 1.561B |
| November 06, 2026 | 1.473B |
| November 05, 2026 | 1.548B |
| November 04, 2026 | 1.622B |
| November 03, 2026 | 1.525B |
| November 02, 2026 | 1.596B |
| October 30, 2026 | 1.627B |
| October 29, 2026 | 1.674B |
| October 28, 2026 | 1.666B |
| October 27, 2026 | 1.634B |
| October 26, 2026 | 1.612B |
| October 23, 2026 | 1.509B |
| October 22, 2026 | 1.490B |
| October 21, 2026 | 1.434B |
| October 20, 2026 | 1.446B |
| October 19, 2026 | 1.436B |
| October 16, 2026 | 1.426B |
| October 15, 2026 | 1.446B |
| October 14, 2026 | 1.410B |
| October 13, 2026 | 1.455B |
| Date | Value |
|---|---|
| October 12, 2026 | 1.441B |
| October 09, 2026 | 1.417B |
| October 08, 2026 | 1.387B |
| October 07, 2026 | 1.398B |
| October 06, 2026 | 1.421B |
| October 05, 2026 | 1.446B |
| October 02, 2026 | 1.444B |
| October 01, 2026 | 1.444B |
| September 30, 2026 | 1.431B |
| September 29, 2026 | 1.436B |
| September 28, 2026 | 1.425B |
| September 25, 2026 | 1.376B |
| September 24, 2026 | 1.342B |
| September 23, 2026 | 1.422B |
| September 22, 2026 | 1.500B |
| September 21, 2026 | 1.509B |
| September 18, 2026 | 1.456B |
| September 17, 2026 | 1.481B |
| September 16, 2026 | 1.502B |
| September 15, 2026 | 1.415B |
| September 14, 2026 | 1.452B |
| September 11, 2026 | 1.473B |
| September 10, 2026 | 1.557B |
| September 09, 2026 | 1.612B |
| September 08, 2026 | 1.666B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Axogen, Inc. | 2.977B |
| Senseonics Holdings, Inc. | 532.95M |
| NeuroPace, Inc. | 294.73M |
| Abbott Laboratories | 213.55B |
| Accuray, Inc. | 100.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.085M |
| Revenue (Quarterly) | 283.03M |
| Total Expenses (Quarterly) | 290.12M |
| EPS Diluted (Quarterly) | -0.1017 |
| Gross Profit Margin (Quarterly) | 56.45% |
| Profit Margin (Quarterly) | -2.50% |
| Earnings Yield | -4.20% |
| Normalized Earnings Yield | -4.203 |